Le rapport « Place des vaccins bivalents contre la Covid-19 Comirnaty Original/Omicron BA.1 et Comirnaty Original/Omicron BA.4-BA.5 », ci-joint, est adopté
Voir aussi
Recommandation vaccinale
20/09/2022
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
0XRnCTBG6Jfeq2Bq
